EGCG upregulates PTEN expression and downregulates PDK1, phospho-Akt, and phospho-mTOR, leading to inhibition of ovarian cancer cell proliferation and induction of apoptosis. This evidence concerns the gene AKT1 and ovarian carcinoma.